Longitudinal association between positive affect and blood lipids in patients following acute myocardial infarction

Mary Princip1, Roland von Känel1, Sinthujan Sivakumar1

  • 1Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Plos One
|November 2, 2023
PubMed

Insights

Positive affect (PA) in myocardial infarction (MI) patients is linked to better blood lipid profiles, specifically higher HDL-C and lower TC/HDL-C ratios, over a year post-MI.

Area of Science:

  • Cardiology
  • Psychology
  • Biochemistry

Background:

  • Unfavorable blood lipid profiles are key predictors of atherosclerotic disease.
  • Positive affect (PA) has been linked to improved lipid profiles.
  • Longitudinal data on PA and lipid profiles in myocardial infarction (MI) patients are scarce.

Purpose of the Study:

  • To prospectively investigate the association between PA and blood lipid levels.
  • To examine changes in PA and lipid profiles over 12 months post-acute MI.

Main Methods:

  • A cohort of 190 MI patients was assessed at admission, 3 months, and 12 months.
  • Linear mixed-effects regression models analyzed the relationship between PA (Global Mood Scale) and lipid levels.
  • Demographic, clinical, and behavioral confounders were controlled.

Main Results:

  • Higher PA correlated with increased high-density lipoprotein cholesterol (HDL-C) and lower total cholesterol (TC)/HDL-C ratio.
  • These associations remained significant after adjusting for multiple factors.
  • No significant association was found between PA and low-density lipoprotein-cholesterol (LDL-C) or triglycerides (TG).

Conclusions:

  • Positive affect is independently associated with favorable HDL-C levels and TC/HDL-C ratio in MI patients up to one year post-event.
  • PA may play a role in cardiovascular health by influencing blood lipid profiles.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
98
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
17
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
167
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
9
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9